Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Mouse IL28A/IFNL2 Polyclonal Antibody

Catalog #:   PMJ19801 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: Q4VK74
Overview

Catalog No.

PMJ19801

Species reactivity

Mouse

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Mouse IL28A/IFNL2 (Asp20-Val193).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Interferon lambda-2 (IFN-lambda-2) (Interleukin-28A) (IL-28A)

Purification

Purified by antigen affinity column.

Accession

Q4VK74

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with IL28A/IFNL2 antibody (PMJ19801) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 22 kDa
    Observed MW: 22 kDa
References

Elevated serum levels of IL-10 family and IL-12 family cytokines in myasthenia gravis., PMID:40288071

Elevated serum levels of IL-10 family and IL-12 family cytokines in myasthenia gravis., PMID:40288071

The Serum ACE2, CTSL, AngII, and TNFα Levels after COVID-19 and mRNA Vaccines: The Molecular Basis., PMID:38137381

The Serum ACE2, CTSL, AngII, and TNFα Levels after COVID-19 and mRNA Vaccines: The Molecular Basis., PMID:38137381

Elevated IL-19 Serum Levels in Patients With Pernicious Anemia and Autoimmune Gastritis., PMID:35479078

Elevated IL-19 Serum Levels in Patients With Pernicious Anemia and Autoimmune Gastritis., PMID:35479078

Serum Th17 and TNF-α distinguish between patients with occult hepatitis B infection, chronic hepatitis B infection and healthy individuals., PMID:34369380

Serum Th17 and TNF-α distinguish between patients with occult hepatitis B infection, chronic hepatitis B infection and healthy individuals., PMID:34369380

Based on G-Series Mouse TH17 Array Study the Effect of Fluoride on C2C12 Cells Cytokines Expression., PMID:33244669

Based on G-Series Mouse TH17 Array Study the Effect of Fluoride on C2C12 Cells Cytokines Expression., PMID:33244669

Chip-based serum proteomics approach to reveal the potential protein markers in the sub-acute stroke patients receiving the treatment of Ginkgo Diterpene Lactone Meglumine Injection., PMID:32413576

Chip-based serum proteomics approach to reveal the potential protein markers in the sub-acute stroke patients receiving the treatment of Ginkgo Diterpene Lactone Meglumine Injection., PMID:32413576

Interleukin 28 is a potential therapeutic target for sepsis., PMID:31121287

Interleukin 28 is a potential therapeutic target for sepsis., PMID:31121287

Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin., PMID:30886417

Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin., PMID:30886417

Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array., PMID:30273784

Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array., PMID:30273784

Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-γ., PMID:28620197

Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-γ., PMID:28620197

Changes in inflammatory cytokine networks in myasthenia gravis., PMID:27172995

Changes in inflammatory cytokine networks in myasthenia gravis., PMID:27172995

Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model., PMID:26886894

Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model., PMID:26886894

IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production., PMID:25941255

IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production., PMID:25941255

Interleukin-28A enhances autoimmune disease in a retinal autoimmunity model., PMID:25138017

Interleukin-28A enhances autoimmune disease in a retinal autoimmunity model., PMID:25138017

Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector., PMID:25008938

Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector., PMID:25008938

Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels., PMID:23954997

Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels., PMID:23954997

Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets., PMID:23637411

Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets., PMID:23637411

Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells., PMID:23021208

Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells., PMID:23021208

Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-κB-mediated MMP-9 expression inducing the MAPK pathway., PMID:22560878

Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-κB-mediated MMP-9 expression inducing the MAPK pathway., PMID:22560878

IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons., PMID:21499846

IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons., PMID:21499846

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway., PMID:21147189

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway., PMID:21147189

A state of acquired IL-10 deficiency in 0.4% of Danish blood donors., PMID:20638860

A state of acquired IL-10 deficiency in 0.4% of Danish blood donors., PMID:20638860

IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet., PMID:17241885

IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet., PMID:17241885

Production, characterization, and applications of two novel monoclonal antibodies against human interleukin-28A., PMID:17176437

Production, characterization, and applications of two novel monoclonal antibodies against human interleukin-28A., PMID:17176437

The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain., PMID:15123776

The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain., PMID:15123776

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Mouse IL28A/IFNL2 Polyclonal Antibody [PMJ19801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only